World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
71
Citations
13510
World Ranking
2364
National Ranking
93

Marc Bijl publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Marc Bijl sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 207 publications — 37th percentile

37% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Marc Bijl D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Marc Bijl sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 71 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Marc Bijl is affiliated with the University Medical Center Groningen in the Netherlands. Their research predominantly focuses on medicine, with a specialization in rheumatology, hematology, pathology and forensic medicine, infectious diseases, and immunology.

They have contributed extensively to the study of autoimmune and inflammatory disorders, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis and related diseases, inflammatory myopathies and dermatomyositis, medical imaging and pathology, and inflammatory bowel disease.

Frequent publication venues for Marc Bijl include:

  • Annals of the Rheumatic Diseases
  • Rheumatology Advances in Practice
  • RMD Open
  • Lara D. Veeken
  • The Journal of Rheumatology

Marc Bijl has collaborated regularly with several researchers, including:

  • Karina de Leeuw
  • Johanna Westra
  • Maarten Limper
  • Christien Rondaan
  • G. Elizabeth Legger

Notable recent publications authored or co-authored by Marc Bijl include:

  • EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021, 2022, Annals of the Rheumatic Diseases
  • Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases, 2021, RMD Open
  • Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts, 2023, Lara D. Veeken
  • Effect of Anti-Rheumatic Treatment on the Periodontal Condition of Rheumatoid Arthritis Patients, 2021, International Journal of Environmental Research and Public Health
  • Effects of Childhood-onset Systemic Lupus Erythematosus on Academic Achievements and Employment in Adult Life, 2020, The Journal of Rheumatology

Best Publications

  • 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    Victoria Furer;Victoria Furer;Christien Rondaan;Marloes W. Heijstek;Nancy Agmon-Levin;Nancy Agmon-Levin

  • EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases

    S van Assen;N Agmon-Levin;O Elkayam;R Cervera

  • Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis

    L. Van Bon;L. Van Bon;A. J. Affandi;A. J. Affandi;J. Broen;J. Broen;R. B. Christmann

  • Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.

    Sander van Assen;Albert Holvast;Cornelis A. Benne;Marcel D. Posthumus

  • Transancestral mapping and genetic load in systemic lupus erythematosus

    Carl D. Langefeld;Hannah C. Ainsworth;Deborah S. Cunninghame Graham;Jennifer A. Kelly

  • EULAR recommendations for vaccination in paediatric patients with rheumatic diseases

    M. W. Heijstek;L. M. Ott de Bruin;M. Bijl;R. Borrow

  • High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus

    Deena A. Abdulahad;Johanna Westra;Johannes Bijzet;Pieter C. Limburg

  • Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement

    Marc Bijl;Esther Reefman;Gerda Horst;Pieter C Limburg

  • Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease

    A Holvast;A Huckriede;J Wilschut;G Horst

  • Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: A systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases

    S. van Assen;O. Elkayam;N. Agmon-Levin;R. Cervera

  • Accelerated atherosclerosis in patients with Wegener's granulomatosis

    de Karina Leeuw;Jan Stephan Sanders;Coen Stegeman;Andries Smit

  • Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus

    Sebastian Dolff;Marc Bijl;Minke G. Huitema;Pieter C. Limburg

  • HMGB1 in vascular diseases: Its role in vascular inflammation and atherosclerosis

    A. W. S. de Souza;Johanna Westra;Pieter Limburg;M. Bijl

  • The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosus.

    Jan-Leendert P Brouwer;Marc Bijl;Nic J G M Veeger;Hanneke C Kluin-Nelemans

  • Replication of recently identified systemic lupus erythematosus genetic associations: a case–control study

    Marian Suarez-Gestal;Manuel Calaza;Emoeke Endreffy;Rudolf Pullmann

  • Efficacy, immunogenicity and safety of vaccination in adult patients with autoimmune inflammatory rheumatic diseases: a systematic literature review for the 2019 update of EULAR recommendations

    Christien Rondaan;Victoria Furer;Victoria Furer;Marloes W Heijstek;Nancy Agmon-Levin;Nancy Agmon-Levin

  • Incidence and prevalence of vaccine preventable infections in adult patients with autoimmune inflammatory rheumatic diseases (AIIRD): A systemic literature review informing the 2019 update of the EULAR recommendations for vaccination in adult patients with AIIRD

    Victoria Furer;Christien Rondaan;Marloes Heijstek;Sander van Assen

  • The Fc gamma RIIIA-158F allele is a risk factor for systemic lupus erythematosus

    Harry R. Koene;Marion Kleijer;Anton J. G. Swaak;Kathleen E. Sullivan

  • Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus

    Sebastian Dolff;Sebastian Dolff;Wayel H. Abdulahad;Johanna Westra;Berber Doornbos-van der Meer

  • Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus

    M Bijl;G Horst;P C Limburg;C G M Kallenberg

Frequent Co-Authors

Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
Pieter C. Limburg
Pieter C. Limburg University of Groningen
Cees G. M. Kallenberg
Cees G. M. Kallenberg University of Groningen
Coen A. Stegeman
Coen A. Stegeman University Medical Center Groningen
Hendrika Bootsma
Hendrika Bootsma University Medical Center Groningen
Elisabeth Brouwer
Elisabeth Brouwer University Medical Center Groningen
Jan Wilschut
Jan Wilschut University Medical Center Groningen
Anke Huckriede
Anke Huckriede University Medical Center Groningen
Torsten Witte
Torsten Witte Hannover Medical School
Juan J. Gomez-Reino
Juan J. Gomez-Reino University of Santiago de Compostela

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career opportunities. Many students consider enrolling in accredited LPN programs easy to get into, which provide a strong foundation in patient care and clinical experience. These programs often serve as stepping stones for advanced nursing roles.

If you're aiming for more advanced practice, the easiest NP program options allow you to obtain nurse practitioner credentials efficiently, balancing quality education with manageable requirements. Specializing further, pursuing one of the best PMHNP programs online can offer excellent clinical placement rates, making it easier to gain practical experience in psychiatric-mental health nursing.

Cost is a significant factor when choosing a degree pathway. Fortunately, several affordable PMHNP programs provide quality education without burdening students with excessive debt. This variety of online options ensures that prospective healthcare professionals can find a balanced approach to advancing their careers in fields related to Immunology.

Explore more about accredited lpn programs easy to get into, the easiest np program, the best pmhnp programs online, and affordable pmhnp programs to find the right educational path that fits your goals.

Best Scientists Citing Marc Bijl

Trending Scientists

Recently Published Articles